GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nanexa AB (OSTO:NANEXA) » Definitions » Days Sales Outstanding

Nanexa AB (OSTO:NANEXA) Days Sales Outstanding : 151.83 (As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Nanexa AB Days Sales Outstanding?

Nanexa AB's average Accounts Receivable for the three months ended in Mar. 2025 was kr4.79 Mil. Nanexa AB's Revenue for the three months ended in Mar. 2025 was kr2.88 Mil. Hence, Nanexa AB's Days Sales Outstanding for the three months ended in Mar. 2025 was 151.83.

The historical rank and industry rank for Nanexa AB's Days Sales Outstanding or its related term are showing as below:

OSTO:NANEXA' s Days Sales Outstanding Range Over the Past 10 Years
Min: 22.8   Med: 93.55   Max: 469.29
Current: 145.84

During the past 11 years, Nanexa AB's highest Days Sales Outstanding was 469.29. The lowest was 22.80. And the median was 93.55.

OSTO:NANEXA's Days Sales Outstanding is ranked worse than
87.04% of 957 companies
in the Drug Manufacturers industry
Industry Median: 72.09 vs OSTO:NANEXA: 145.84

Nanexa AB's Days Sales Outstanding increased from Mar. 2024 (98.44) to Mar. 2025 (151.83).


Nanexa AB Days Sales Outstanding Historical Data

The historical data trend for Nanexa AB's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanexa AB Days Sales Outstanding Chart

Nanexa AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 147.19 105.86 93.55 22.80 35.43

Nanexa AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 98.44 182.39 107.11 90.81 151.83

Competitive Comparison of Nanexa AB's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Nanexa AB's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nanexa AB's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nanexa AB's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Nanexa AB's Days Sales Outstanding falls into.


;
;

Nanexa AB Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Nanexa AB's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

Days Sales Outstanding (A: Dec. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Dec. 2024 )) / count ) / Revenue (A: Dec. 2024 )*Days in Period
=( (2.48 + 2.25) / 2 ) / 24.361*365
=2.365 / 24.361*365
=35.43

Nanexa AB's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

Days Sales Outstanding (Q: Mar. 2025 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2024 ) + Accounts Receivable (A: Mar. 2025 )) / count ) / Revenue (A: Mar. 2025 )*Days in Period
=( (2.25 + 7.324) / 2 ) / 2.877*365 / 4
=4.787 / 2.877*365 / 4
=151.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nanexa AB  (OSTO:NANEXA) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Nanexa AB Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Nanexa AB's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanexa AB Business Description

Traded in Other Exchanges
Address
Virdings Alle 32B, Uppsala, SWE, 75450
Nanexa AB is a pharmaceutical company developing injectable drug products based on the proprietary drug delivery system PharmaShell - the high drug load delivery system enabling the next generation long-acting injectables through atomic layer precision. The company develops its products and also has collaboration agreements with several pharma companies, among others AstraZeneca. Geographically, the company derives maximum revenue from Nordic countries.

Nanexa AB Headlines

No Headlines